This compound is a pharmaceutical intermediate with a thiazole core and a nitrile-substituted phenol group. Its structure features aromatic rings, an ester functional group, and moderate polarity, indicating potential utility in organic synthesis and drug development.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 161798-02-3
Ethyl 2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate
pharmaceutical intermediate
Cis-Octahydro-1H-isoindole hydrochloride
Pharmaceutical intermediate for drug synthesis
Alogliptin Impurity 07
Pharmaceutical impurity reference standard
3-QUINUCLIDINOL
precursor in pharmaceutical synthesis
5-Thiazolecarboxylic acid, 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester
Pharmaceutical intermediate
Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate
pharmaceutical intermediate
Ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
Pharmaceutical intermediate for thiazole derivatives
Febuxostate
active pharmaceutical ingredient
ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
WTMZFYPEMMFHPR-UHFFFAOYSA-N
CCOC(=O)C1=C(N=C(S1)C2=CC(=C(C=C2)O)C#N)C